Changchun Genescience Pharmaceutical Co., Ltd.

This early-stage study tests a new drug called GenSci140 in people with advanced solid tumors, including ovarian cancer. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 170 participants will be enrolled in China.

This early-stage study is testing a new drug called GenSci139 in about 280 adults with advanced solid tumors that have spread. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. The study is currently recruiting participants.

This study looks at how well a drug called nanocrystalline megestrol acetate works for cancer patients who have cachexia, a condition causing severe weight loss and poor appetite. About 495 adults with cancer will take the drug, and researchers will check if their appetite and we…